{"id":"CHEMBL1098","canonicalSmiles":"CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C","inchiKey":"LEBVLXFERQHONN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"BUPIVACAINE","yearOfFirstApproval":1972,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Anekain","Exparel","Marcaine","Posimir","Sensorcaine"],"synonyms":["Bucaine","Bupivacaine","Bupivacaine liposome","LIQ-865","LIQ865","Liposomal bupivacaine","Marcaine","Ropivacaine hydrochloride impurity, bupivacaine-","SKY-0402","SKY0402","Sensorcaine"],"crossReferences":{"DailyMed":["bupivacaine","bupivacaine%20hydrochloride"],"PubChem":["160644527"],"Wikipedia":["Bupivacaine"],"drugbank":["DB00297"],"chEBI":["77431"]},"childChemblIds":["CHEMBL1200396"],"linkedTargets":{"rows":["ENSG00000007314"],"count":1},"linkedDiseases":{"rows":["EFO_0004710","EFO_0005232","EFO_0003869","EFO_1001139","EFO_0003777","EFO_0011061","EFO_0007486","EFO_1001178","HP_0030838","HP_0012227","HP_0012735","EFO_0000275","MONDO_0002959","MONDO_0004567","HP_0000175","HP_0031217","EFO_1001909","EFO_1000994","EFO_0003964","EFO_0003931","HP_0100790","MONDO_0002471","EFO_1000786","MONDO_0008903","EFO_1001898","EFO_1001331","EFO_0004616","HP_0003419","EFO_0009552","EFO_1002012","EFO_0009620","EFO_0003877","EFO_1001250","EFO_0005762","EFO_0002618","HP_0000016","EFO_0001074","HP_0012532","HP_0001623","EFO_0009512","EFO_0010072","HP_0009926","EFO_1001968","EFO_0009867","MONDO_0008315","HP_0030016","EFO_0000546","MP_0001914","HP_0001537","HP_0002027","HP_0003040","EFO_0000731","EFO_0003957","EFO_0004888","EFO_0004209","EFO_0000342","EFO_1001792","EFO_0005251","EFO_0004248","MONDO_0004880","MONDO_0021117","EFO_0008507","MONDO_0007254","EFO_0000284","MONDO_0002087","MONDO_0004565","EFO_0002950","MONDO_0005277","MONDO_0022394","EFO_0009514","EFO_1001866","EFO_0007202","HP_0030834","EFO_0004143","HP_0100749","EFO_1000362","HP_0001822","EFO_0009625","EFO_0007490","EFO_0000616","EFO_0004210","HP_0000486","EFO_1001267","HP_0003418","EFO_0003818","EFO_0001073","EFO_0003843","EFO_0003060","HP_0002315","EFO_0000311","EFO_0000537","EFO_0007149","Orphanet_98578","EFO_1001412","EFO_0004229","EFO_0009614","MONDO_0021148","EFO_0000764","HP_0000020","EFO_0004273","EFO_0001421","EFO_0005611","EFO_0009314","EFO_0003833","MONDO_0005178","HP_0000023","EFO_0000691","EFO_0003944","EFO_0009615","HP_0003470"],"count":110},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1972 and is indicated for hernia and pain and has 67 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200328","canonicalSmiles":"CNCC[C@H](Oc1cccc2ccccc12)c1cccs1.Cl","inchiKey":"BFFSMCNJSOPUAY-LMOVPXPDSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DULOXETINE HYDROCHLORIDE","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1175","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ariclaim","Cymbalta","Drizalma sprinkle","Duciltia","Duloxetine hydrochloride","Yentreve"],"synonyms":["Ariclaim","Duloxetine (as hydrochloride)","Duloxetine hcl","Duloxetine hydrochloride","Duloxetine mylan","LY-248686","LY-248686 HCL","LY248686 HCL","NSC-759112","Xeristar"],"crossReferences":{"DailyMed":["duloxetine%20hydrochloride"],"PubChem":["144205741","170465319","49681598"],"chEBI":["31526"]},"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546"],"count":2},"linkedDiseases":{"rows":["EFO_0005762","EFO_0002970","EFO_0005687","EFO_0006788","HP_0012532","MONDO_0002009","EFO_0001358","EFO_0003843","EFO_1001951","EFO_1000783","MONDO_0002050","MONDO_0005301","HP_0000020","EFO_0003761","EFO_0005230","MONDO_0005178"],"count":16},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and has 7 approved and 9 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200393","canonicalSmiles":"Cc1c(F)c(N2CCNC(C)C2)cc2c1c(=O)c(C(=O)O)cn2C1CC1.Cl","inchiKey":"IEPMBYOIQGCVHO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GREPAFLOXACIN HYDROCHLORIDE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL583","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"," United Kingdom"," United States"," Germany"],"classes":["Cardiotoxicity"],"year":1999},"tradeNames":["Raxar"],"synonyms":["Grepafloxacin hcl","Grepafloxacin hydrochloride","OPC-17116"],"crossReferences":{"PubChem":["144206077","170466148"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1997. It was withdrawn in United States,  United Kingdom,  United States and  Germany initially in 1999 due to Cardiotoxicity."}
{"id":"CHEMBL1200544","canonicalSmiles":"CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1.O","inchiKey":"AVGYWQBCYZHHPN-CYJZLJNKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEPHALEXIN","yearOfFirstApproval":1971,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1727","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cephalexin","Ceporex","Keflet","Keflex","Kiflone","Panixine disperdose","Tenkorex"],"synonyms":["66873","Cefalexin","Cefalexin hydrate","Cefalexin monohydrate","Cefanex","Cephalexin","Cephalexin monohydrate","LY-66873","NSC-758162"],"crossReferences":{"chEBI":["3535"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1971 and has 6 approved and 11 investigational indications."}
{"id":"CHEMBL1200714","canonicalSmiles":"CN1C(=O)CCS(=O)(=O)C1c1ccc(Cl)cc1","inchiKey":"WEQAYVWKMWHEJO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORMEZANONE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"," European Union"," Germany"," France"," Japan"," Pakistan"," Portugal"," United Arab Emirates"," Zimbabwe"," Saudi Arabia"],"classes":["Dermatological toxicity"," Hepatotoxicity"],"year":1996},"tradeNames":["Lyseen new","Trancopal"],"synonyms":["Chlormethazanone","Chlormezanone","NSC-169108"],"crossReferences":{"PubChem":["104171118","144203644","144206702","144212514","170465161","26747112","26751725","50104419","85230949","90340648"],"TG-GATEs":["52"],"Wikipedia":["Chlormezanone"],"drugbank":["DB01178"],"chEBI":["3619"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1960. It was withdrawn in United States,  European Union,  Germany,  France,  Japan,  Pakistan,  Portugal,  United Arab Emirates,  Zimbabwe and  Saudi Arabia initially in 1996 due to Dermatological toxicity and  Hepatotoxicity."}
{"id":"CHEMBL1200771","canonicalSmiles":"CC[N+](CC)(CC)CCC(O)(c1ccccc1)C1CCCCC1.[Cl-]","inchiKey":"XJGONMZLEDGBRM-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIDIHEXETHYL CHLORIDE","yearOfFirstApproval":1954,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201354","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pathilon"],"synonyms":["Tridihexethyl chloride"],"crossReferences":{"PubChem":["144204284","56463141"],"chEBI":["9703"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1954."}
{"id":"CHEMBL1200859","canonicalSmiles":"CCN(CC)c1ccc(C(=C2C=CC(=[N+](CC)CC)C=C2)c2cc(S(=O)(=O)[O-])ccc2S(=O)(=O)[O-])cc1.[Na+]","inchiKey":"NLUFDZBOHMOBOE-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOSULFAN BLUE","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201275","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Isosulfan blue","Lymphazurin"],"synonyms":["Acid blue 1","Acid blue v","C.i. 42045","C.i. acid blue 1","C.i. food blue 3","Ci 42045","Food blue 3","Iso-sulfan blue","Isosulfan blue","NSC-734902","P-1888","P-4125","Patent blue vf","Patent blue violet","Sulfan blue","Sulphan blue","Sulphan blue 2,5-disulfophenyl isomer"],"crossReferences":{"DrugCentral":["4503"],"PubChem":["170464639"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1981 and has 1 investigational indication."}
{"id":"CHEMBL1200912","canonicalSmiles":"CC(C)(N)Cc1ccccc1.Cl","inchiKey":"NCAIGTHBQTXTLR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENTERMINE HYDROCHLORIDE","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1574","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adipex-p","Fastin","Lomaira","Obestin-30","Oby-trim","Ona-mast","Phentermine hydrochloride","Suprenza","Tora","Wilpo"],"synonyms":["NSC-44090","Phentermine hcl","Phentermine hydrochloride","Phentermine hydrochloride civ","Zantryl"],"crossReferences":{"DailyMed":["phentermine%20hydrochloride"],"chEBI":["50506"]},"linkedTargets":{"rows":["ENSG00000103546"],"count":1},"linkedDiseases":{"rows":["EFO_0003144","EFO_0001073"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1973 and is indicated for obesity."}
{"id":"CHEMBL1201081","canonicalSmiles":"C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)COC(=O)CCC(=O)[O-])[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12.[Na+]","inchiKey":"FQISKWAFAHGMGT-SGJOWKDISA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLPREDNISOLONE SODIUM SUCCINATE","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201265","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["A-methapred","Methylprednisolone","Methylprednisolone sodium succinate","Min-i-mix","Solu-medrol","Solu-medrone","Urbasone"],"synonyms":["Methylprednisolone 21-succinate sodium salt","Methylprednisolone sodium succinate","NSC-48989"],"crossReferences":{"DailyMed":["methylprednisolone%20sodium%20succinate"],"PubChem":["144207076"]},"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_1001222","EFO_0000275","EFO_0004228","EFO_0003778","EFO_0001379","EFO_0009267","EFO_0005952","MONDO_0002462","EFO_0000540","EFO_0000565","EFO_0000474","MONDO_0002280","MONDO_0002471","EFO_0002690","EFO_0003884","EFO_0004616","EFO_0004143","Orphanet_700","EFO_0007332","EFO_0005140","EFO_0008522","EFO_1001272","EFO_0000198","MONDO_0013730","EFO_0000694","EFO_0000685","Orphanet_701","EFO_0000220","EFO_0007537","EFO_1001466","EFO_0000222","EFO_0004194","EFO_0003894","EFO_0004599","EFO_0003843","EFO_0002609","EFO_1001119","EFO_0003106","HP_0100806","MP_0001845","EFO_0003840","MONDO_0100096","MONDO_0005301","EFO_0000095","EFO_0007359","MONDO_0002406","EFO_0000574","MONDO_0004979","EFO_0000341","EFO_0001378","MONDO_0005178","EFO_0001063"],"count":52},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1959 and has 16 approved and 24 investigational indications."}
{"id":"CHEMBL1201182","canonicalSmiles":"CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C","inchiKey":"CBPNZQVSJQDFBE-FUXHJELOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEMSIROLIMUS","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Torisel"],"synonyms":["CCI-779","Temsirolimus"],"crossReferences":{"DailyMed":["temsirolimus"],"PubChem":["144206068"],"Wikipedia":["Temsirolimus"],"drugbank":["DB06287"],"chEBI":["79699"]},"linkedTargets":{"rows":["ENSG00000088832"],"count":1},"linkedDiseases":{"rows":["EFO_0003869","EFO_0000637","EFO_0000365","EFO_0000756","EFO_0000681","EFO_1000231","MONDO_0004222","EFO_0005952","EFO_1001187","EFO_0000228","EFO_0002917","EFO_0000632","EFO_0000565","EFO_1001952","EFO_0000339","MONDO_0002974","MONDO_0003268","EFO_1001331","MONDO_0008903","EFO_0000182","EFO_1000251","EFO_0000389","EFO_1000440","EFO_0000198","EFO_0000466","EFO_1000292","MONDO_0002108","EFO_0000248","MONDO_0008170","EFO_0000349","EFO_1001512","EFO_1001968","EFO_0000502","EFO_1000441","MONDO_0008315","EFO_0009708","EFO_1000026","MONDO_0002691","MONDO_0000544","EFO_1000238","EFO_0000574","MONDO_0002863","EFO_1000613","EFO_0001378","EFO_1000412","MONDO_0004192","EFO_0007416","MONDO_0015686","EFO_1001465","MONDO_0007254","EFO_1001469","MONDO_0021063","MONDO_0002087","EFO_0000305","MONDO_0020654","MONDO_0001187","MONDO_0016691","EFO_1001480","MONDO_0002158","EFO_1000044","EFO_0000673","EFO_0002499","EFO_0000183","MONDO_0024677","EFO_0000707","EFO_1000037","EFO_1000158","EFO_0002914","EFO_0000616","EFO_0000685","EFO_0000437","EFO_0000403","EFO_0000232","EFO_0003929","EFO_0000222","EFO_0000313","EFO_0002501","EFO_0000556","EFO_0003060","EFO_0000621","EFO_0000311","MONDO_0016693","EFO_0006861","MONDO_0011962","EFO_0000702","MONDO_0017386","MONDO_0002367","MONDO_0024880","EFO_0000691","EFO_0000519","EFO_0000181","EFO_0004265","EFO_0003833"],"count":93},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2007 and has 4 approved and 71 investigational indications."}
{"id":"CHEMBL1201545","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN SUSP ISOPHANE BEEF","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nph insulin"],"synonyms":["Insulin susp isophane beef"],"linkedTargets":{"rows":["ENSG00000171105"],"count":1},"linkedDiseases":{"rows":["EFO_0004593","MONDO_0005147","HP_0003074","EFO_0000400","MONDO_0005148"],"count":5},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and has 3 investigational indications."}
{"id":"CHEMBL1201585","drugType":"Antibody","blackBoxWarning":true,"name":"TRASTUZUMAB","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Herceptin","Kadcyla"],"synonyms":["4D5V8","ABP 980","ABP-980","Abp-980 (trastuzumab biosimilar)","Bmab-200","Canhera","DMB-3111 (TRASTUZUMAB BIOSIMILAR)","Dmb-3111","EG-12014","EG12014","Eg12014 trastuzumab biosimilar","Herzuma","Kanjinti","Ogivri","Ontruzant","Pf-05280014","R-597","Rhumab her2","SYD-977","SYD977","Sb-3 (trastuzumab biosimilar)","Trastuzumab","Trastuzumab (herceptin)","Trastuzumab beta","Trastuzumab biosimilar (abp-980)","Trastuzumab-anns","Trastuzumab-dkst","Trastuzumab-dttb","Trastuzumab-pfizer","Trastuzumab-pkrb","Trastuzumab-qyyp","Trastuzumab-zzxf","Trazimera"],"crossReferences":{"DailyMed":["trastuzumab","trastuzumab-anns","trastuzumab-dkst","trastuzumab-dttb","trastuzumab-pkrb"],"DrugCentral":["4979"],"Wikipedia":["Trastuzumab"]},"linkedTargets":{"rows":["ENSG00000141736"],"count":1},"linkedDiseases":{"rows":["EFO_0005232","MONDO_0003060","EFO_0003869","EFO_0000637","EFO_0005952","EFO_1001187","EFO_0000228","EFO_1000984","EFO_1001951","EFO_0000565","MONDO_0002974","MONDO_0008903","MONDO_0001528","MONDO_0005411","EFO_0000501","EFO_0000641","EFO_1000028","EFO_0002618","EFO_0005922","MONDO_0019465","MONDO_0021321","MONDO_0008170","EFO_0000701","MONDO_0004669","EFO_1001512","MONDO_0044915","MONDO_0004986","MONDO_0008315","EFO_0005221","MONDO_0001879","EFO_0009708","EFO_1000307","Orphanet_398934","EFO_0000549","EFO_0005537","EFO_0000432","EFO_0006544","EFO_1001051","EFO_1000796","EFO_0009637","MONDO_0044964","MONDO_0004192","MONDO_0007254","MONDO_0001370","MONDO_0003196","MONDO_0002087","EFO_0000305","MONDO_0003510","MONDO_0020654","MONDO_0021165","MONDO_0001187","MONDO_0001056","EFO_1001480","MONDO_0002158","EFO_1000044","MONDO_0021311","EFO_0006352","EFO_0003968","EFO_0000183","EFO_0005588","EFO_0000616","MONDO_0001402","EFO_0003897","EFO_0006859","EFO_0005774","EFO_0006318","EFO_0002916","EFO_0000503","EFO_0000478","MONDO_0007576","EFO_0000313","EFO_0000222","EFO_0003060","EFO_0000311","EFO_0003863","EFO_0000304","EFO_0006861","EFO_0008549","MONDO_0011962","EFO_0004142","MONDO_0003219","MONDO_0024880","EFO_0000691","MONDO_0044926"],"count":84},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and has 5 approved and 61 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1213250","canonicalSmiles":"Cn1c(N)c(NC(=O)NCCN)c[n+]1CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)/C(=N\\OC(C)(C)C(=O)[O-])c3nsc(N)n3)[C@H]2SC1.O=S(=O)(O)O","inchiKey":"UJDQGRLTPBVSFN-TVNHLQOTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFTOLOZANE SULFATE","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2103872","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["CXA-101 (FOR SULFATE)","Ceftolozane sulfate","FR-264205","FR264205"],"crossReferences":{"DailyMed":["ceftolozane%20sulfate"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and is indicated for urinary tract infection and infection."}
{"id":"CHEMBL1231661","canonicalSmiles":"CC(C)(O/N=C(\\C(=O)NCB(O)O)c1csc(N)n1)C(=O)O","inchiKey":"ZECCQELUYUPTSB-UUASQNMZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFTAZIDIME BATSI","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ceftazidime Batsi"],"crossReferences":{"drugbank":["DB04035"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231891","canonicalSmiles":"Cc1c2[nH]c(c1CCC(=O)O)Cc1[nH]c(c(CCC(=O)O)c1C)Cc1[nH]c(c(CCC(=O)O)c1C)Cc1[nH]c(c(C)c1CCC(=O)O)C2","inchiKey":"NIUVHXTXUXOFEB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"COPROPORPHYRINOGEN-III","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Coproporphyrinogen-Iii"],"crossReferences":{"drugbank":["DB04461"],"chEBI":["15439"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234930","canonicalSmiles":"CCCCCCCC(=O)O[C@H](CC(=O)O)C[N+](C)(C)C","inchiKey":"CXTATJFJDMJMIY-CYBMUJFWSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"OCTANOYLCARNITINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11113593"],"drugbank":["DB03832"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235716","canonicalSmiles":"CCC(N)=O","inchiKey":"QLNJFJADRCOGBJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROPIONAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04161"],"chEBI":["45422"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236126","canonicalSmiles":"CC(C)(C)C(=O)Oc1ccc2c(c1)nc(NC(=O)c1cccc([N+](=O)[O-])c1)n2CCCO","inchiKey":"CEAYRKIZESVQSN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1236126","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["103905081","137275845"],"drugbank":["DB08590"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1237021","canonicalSmiles":"O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1C[C@@H]1CCCC[C@H]1CN1CCN(c2nsc3ccccc23)CC1","inchiKey":"PQXKDMSYBGKCJA-CVTJIBDQSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LURASIDONE","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Latuda"],"synonyms":["Lurasidone"],"crossReferences":{"DailyMed":["lurasidone%20hydrochloride"],"Wikipedia":["Lurasidone"],"drugbank":["DB08815"],"chEBI":["70735"]},"childChemblIds":["CHEMBL1615372"],"linkedTargets":{"rows":["ENSG00000149295","ENSG00000102468"],"count":2},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0000289","MONDO_0002050","MONDO_0002009","EFO_0000677","EFO_0003758","EFO_0009963","EFO_0005407","EFO_0005411"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and has 5 approved and 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1241590","canonicalSmiles":"CS(=O)(=O)c1ccc([C@@H](O)[C@@H](CF)NC(=O)C(Cl)Cl)cc1","inchiKey":"AYIRNRDRBQJXIF-NXEZZACHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLORFENICOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Florfenicol","NSC-759287","Nuflor","SCH 25298","SCH-25298"],"crossReferences":{"PubChem":["144204234","170465648","56463547"],"Wikipedia":["Florfenicol"],"drugbank":["DB11413"],"chEBI":["87185"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1256472","canonicalSmiles":"Cl.Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1","inchiKey":"KCURWTAZOZXKSJ-JBMRGDGGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYTARABINE HYDROCHLORIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL803","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cytarabine hcl","Cytarabine hydrochloride","Cytosine arabinoside hydrochloride","NSC-63878","U-19920A"],"crossReferences":{"PubChem":["144210806","50106080","56424029","8139915"]},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1256819","canonicalSmiles":"Cl.c1ccc(CN(CC2=NCCN2)c2ccccc2)cc1","inchiKey":"SWKDMSRRIBZZAY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANTAZOLINE HYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1305","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Antaz hcl","R.b.c."],"synonyms":["Antazoline hcl","Antazoline hydrochloride"],"crossReferences":{"PubChem":["144204075","170464765","56422365","56463312","855763"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1437847","canonicalSmiles":"Nc1ccc(S(=O)(=O)Nc2cnc3ccccc3n2)cc1","inchiKey":"NHZLNPMOSADWGC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFAQUINOXALINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-41805","Sulfaquinoxaline"],"crossReferences":{"PubChem":["144203578","144211211","170465653","26665745","4252936","96536"],"drugbank":["DB11464"]},"childChemblIds":["CHEMBL1527324"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1467","canonicalSmiles":"O=c1ncnc2[nH][nH]cc1-2","inchiKey":"OFCNXPDARWKPPY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALLOPURINOL","yearOfFirstApproval":1966,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Allopurinol","Aloral","Aluline 100","Aluline 300","Caplenal","Cosuric","Hamarin 100","Hamarin 300","Ledopur","Lopurin","Uricto","Xanthomax-100","Xanthomax-300","Zyloprim","Zyloric","Zyloric-300"],"synonyms":["Allopurinol","Allopurinolum","BW 56-158","BW-56-158","NSC-101655","NSC-1390","Suspendol","Takanarumin"],"crossReferences":{"DailyMed":["allopurinol","allopurinol%20sodium"],"PubChem":["11110781","144203633","144208120","170464935","17389550","174007214","26747845","50105533","56424020","8139898","90341357"],"TG-GATEs":["28"],"Wikipedia":["Allopurinol"],"drugbank":["DB00437"],"chEBI":["40279"]},"childChemblIds":["CHEMBL1200477"],"linkedTargets":{"rows":["ENSG00000158125"],"count":1},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0000729","EFO_0003777","EFO_0004274","EFO_0000401","EFO_0000373","EFO_0005952","MONDO_0002087","MONDO_0003541","EFO_1001793","EFO_0003913","EFO_0000565","EFO_1000653","Orphanet_46","EFO_0004251","EFO_0000289","MONDO_0002158","EFO_0009582","EFO_0003144","EFO_0000712","EFO_0003884","EFO_0004253","Orphanet_976","EFO_1001479","EFO_0000094","EFO_0000400","EFO_1001893","EFO_0000198","EFO_0009104","EFO_0005044","EFO_0000220","MONDO_0008170","EFO_0005207","EFO_0000222","Orphanet_3389","EFO_0000319","EFO_1001946","EFO_0001073","EFO_0000537","EFO_0000311","EFO_0000195","MONDO_0001134","EFO_0000095","EFO_0000702","EFO_0000574","EFO_1001947","EFO_0001378","MONDO_0005148","EFO_0005411","EFO_0003767","EFO_0005672","MONDO_0005178","EFO_0004265"],"count":53},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1966 and has 4 approved and 36 investigational indications."}
{"id":"CHEMBL1491306","canonicalSmiles":"Oc1cc(Cc2ccccc2)nc(S)n1","inchiKey":"PNXBXCRWXNESOV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZYLTHIOURACIL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Basdene"],"synonyms":["Bentiuracil","Benzylthiouracil","NSC-39511","NSC-6508"],"crossReferences":{"PubChem":["22402305"],"drugbank":["DB13804"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for abnormality of the thyroid gland."}
{"id":"CHEMBL1497","canonicalSmiles":"CCCCC(=O)O[C@]1(C(=O)CO)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C","inchiKey":"SNHRLVCMMWUAJD-SUYDQAKGSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"BETAMETHASONE VALERATE","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Audavate","Audavate rd","Beta-val","Betacap","Betaderm","Betameth val in coal tar","Betamethasone valerate","Betatrex","Betesil","Betnovate rd","Betnovate-c","Betnovate-n","Bettamousse","Bextasol","Dermabet","Fucibet","Luxiq","Valisone","Valnac","Xemacort"],"synonyms":["Betamethasone (as valerate)","Betamethasone 17-valerate","Betamethasone valerate","Betamethasoni valeras","NSC-755912","Rinderon v","Stanoval","Tokuderm"],"crossReferences":{"DailyMed":["betamethasone%20valerate"],"PubChem":["144212605"],"Wikipedia":["Betamethasone_17-valerate"],"chEBI":["31277"]},"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["HP_0006536","EFO_1001494","HP_0000964","EFO_1001818","EFO_0000701","EFO_0000676","EFO_0009552","EFO_0000274","MONDO_0043771","HP_0001742","HP_0004798","EFO_0005752"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1967 and has 5 approved and 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1556","canonicalSmiles":"O=c1[nH]cnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O","inchiKey":"UGQMRVRMYYASKQ-KQYNXXCUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INOSINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hypoxanthine riboside","Hypoxanthosine","INO-1001","Inosine","Inotin","NSC-20262"],"crossReferences":{"PubChem":["144205075","170465655","8139984"],"Wikipedia":["Inosine"],"drugbank":["DB04335"],"chEBI":["17596"]},"childChemblIds":["CHEMBL1213651"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 11 investigational indications."}
{"id":"CHEMBL1569487","canonicalSmiles":"CN1C(C(=O)Nc2ccccn2)=C(O)c2sc(Cl)cc2S1(=O)=O","inchiKey":"WLHQHAUOOXYABV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LORNOXICAM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Xefo"],"synonyms":["CTX","Lorcam","Lornoxicam","NSC-759620","RO 13-9297","RO-13-9297","RO-139297"],"crossReferences":{"PubChem":["49666507"],"drugbank":["DB06725"],"chEBI":["31783"]},"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["MONDO_0005277","MONDO_0004975","EFO_0003843","EFO_0005755","EFO_0005672"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for rheumatic disease and has 3 investigational indications."}
{"id":"CHEMBL1615369","canonicalSmiles":"CCCCCCOC(=O)/N=C(\\N)c1ccc(NCc2nc3cc(C(=O)N(CCC(=O)OCC)c4ccccn4)ccc3n2C)cc1.CS(=O)(=O)O","inchiKey":"XETBXHPXHHOLOE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DABIGATRAN ETEXILATE MESYLATE","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL539697","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pradaxa"],"synonyms":["BIBR 1048 MS","BIBR-1048-MS","Dabigatran etexilate mesilate","Dabigatran etexilate mesylate"],"crossReferences":{"DailyMed":["dabigatran%20etexilate%20mesylate"],"chEBI":["70743"]},"linkedTargets":{"rows":["ENSG00000180210"],"count":1},"linkedDiseases":{"rows":["EFO_0000275","EFO_0000712","EFO_1000652","EFO_0003907"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and has 3 approved and 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1623","canonicalSmiles":"Cc1cccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1","inchiKey":"OCJYIGYOJCODJL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MECLIZINE","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Meclizine","Meclozine","NSC-169189"],"crossReferences":{"DailyMed":["meclizine%20hydrochloride"],"Wikipedia":["Meclozine"],"drugbank":["DB00737"],"chEBI":["6709"]},"childChemblIds":["CHEMBL1200590","CHEMBL1324020","CHEMBL3989555","CHEMBL1085765"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0004319","EFO_0006928","HP_0002017","HP_0002321","EFO_0000182","MONDO_0005271","HP_0002013","HP_0002018"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1957 and has 6 approved and 3 investigational indications."}
{"id":"CHEMBL1670","canonicalSmiles":"Clc1ccc(C(c2ccccc2Cl)C(Cl)Cl)cc1","inchiKey":"JWBOIMRXGHLCPP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MITOTANE","yearOfFirstApproval":1970,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lysodren","Opddd"],"synonyms":["CB 313","CB-313","Chloditan","Chlodithane","Mitotan","Mitotane","NSC-38721","O,p'-ddd","O,p'-ddd,o p'-tde","O,p'-tde","Opeprim"],"crossReferences":{"DailyMed":["mitotane"],"PubChem":["104171128","144203654","144213121","170464927","17389949","174007193","26747348","26752984","50105583","56462780","85230966","90341596","94579"],"Wikipedia":["Mitotane"],"drugbank":["DB00648"]},"linkedTargets":{"rows":["ENSG00000140459","ENSG00000160882"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000313","EFO_1000796","MONDO_0008315"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1970 and is indicated for neoplasm and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1743082","drugType":"Antibody","blackBoxWarning":true,"name":"TRASTUZUMAB EMTANSINE","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Ado-trastuzumab emtansine","PRO-132365","RG-3502","TRASTUZUMAB-MCC-DM1 T-DM1","Trastuzumab emtansine"],"crossReferences":{"DailyMed":["ado-trastuzumab%20emtansine"],"DrugCentral":["4990"]},"linkedTargets":{"rows":["ENSG00000261456","ENSG00000188229","ENSG00000104833","ENSG00000137267","ENSG00000258947","ENSG00000101162","ENSG00000141736","ENSG00000196230","ENSG00000137285","ENSG00000176014"],"count":10},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003869","MONDO_0008170","MONDO_0007254","MONDO_0004669","EFO_0000305","EFO_0003060","EFO_0000311","EFO_0009708","MONDO_0001056","EFO_0000304","EFO_1001480","MONDO_0011962","EFO_0001378"],"count":14},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and has 5 approved and 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1770","canonicalSmiles":"Cl.c1ccc([C@H]2CN3CCSC3=N2)cc1","inchiKey":"LAZPBGZRMVRFKY-HNCPQSOCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVAMISOLE HYDROCHLORIDE","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1454","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ergamisol","Ketrax","Solaskil"],"synonyms":["Ascaridil","L-narpenol","Levamisole hcl","Levamisole hydrochloride","Levamisoli hydrochloridum","NSC-177023","R 12,564","R 12654","R-12564","Spartakon l","Tetramisole hydrochloride, (s)-"],"crossReferences":{"PubChem":["144204834","170465293","50106504","564189","56463293"],"chEBI":["6433"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1990 and has 2 investigational indications."}
{"id":"CHEMBL190729","canonicalSmiles":"CC1=C(C(=O)Nc2ccc(Cl)c(C(=O)OC(C)C)c2)SCCO1","inchiKey":"FMQGUMRNTBJHEA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL190729","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["487570"],"drugbank":["DB08682"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1908364","canonicalSmiles":"O=C1CC[C@@](c2ccccc2)(C2CCN(Cc3ccccc3)CC2)C(=O)N1","inchiKey":"LQQIVYSCPWCSSD-HSZRJFAPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXETIMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Benzetimide, (s)-","Dexetimide","R 16,470 [AS HYDROCHLORIDE]"],"crossReferences":{"drugbank":["DB08997"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL19449","canonicalSmiles":"CC(C)C(=O)c1c(C(C)C)nn2ccccc12","inchiKey":"ZJVFLBOZORBYFE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IBUDILAST","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AV-411","AV411","Ibudilast","Ketas","MN-166"],"crossReferences":{"PubChem":["11114182","124880396","124880398","144207052","170466049","46500478","50104937","90341511"],"Wikipedia":["Ibudilast"],"drugbank":["DB05266"]},"linkedTargets":{"rows":["ENSG00000065989","ENSG00000105650","ENSG00000112541","ENSG00000113448","ENSG00000172572","ENSG00000138735","ENSG00000184588"],"count":7},"linkedDiseases":{"rows":["MONDO_0005277","HP_0006536","EFO_0003840","EFO_1000783","MONDO_0002491","EFO_0005611","MONDO_0004976","MONDO_0007079","EFO_0004701","HP_0002196","EFO_0003843","EFO_0000519","EFO_0007541"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 13 investigational indications."}
{"id":"CHEMBL2036958","canonicalSmiles":"CC1(CCCc2cc(=O)oc3[nH]c(=O)[nH]c(=O)c23)CC1","inchiKey":"ARJKMWXLIHZLQZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SCH-900271","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SCH 900271","Sch 900271","Sch-900271"],"crossReferences":{"drugbank":["DB12433"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2103797","canonicalSmiles":"Cc1cn([C@H]2C[C@H](O)[C@@H](COP(=O)([O-])O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(=O)([O-])O[C@@H]3[C@@H](COP(=O)([O-])O[C@@H]4[C@@H](COP(=O)([O-])O[C@@H]5[C@@H](COP(=O)([O-])O[C@@H]6[C@@H](COP(=O)([O-])O[C@@H]7[C@@H](COP(=O)([O-])O[C@@H]8[C@@H](COP(=O)([O-])O[C@@H]9[C@@H](COP(=O)([O-])O[C@@H]%10[C@@H](COP(=O)([O-])O[C@@H]%11[C@@H](COP(=O)([O-])O[C@@H]%12[C@@H](COP(=O)([O-])O[C@@H]%13[C@@H](COP(=O)([O-])O[C@@H]%14[C@@H](COP(=O)([O-])O[C@@H]%15[C@@H](COP(=O)([O-])O[C@@H]%16[C@@H](COP(=O)([O-])O[C@@H]%17[C@@H](COP(=O)([O-])O[C@@H]%18[C@@H](COP(=O)([O-])O[C@@H]%19[C@@H](COP(=O)([O-])O[C@@H]%20[C@@H](COP(=O)([O-])O[C@@H]%21[C@@H](CO)O[C@@H](n%22cnc%23c(N)ncnc%23%22)[C@@H]%21O)O[C@@H](n%21ccc(N)nc%21=O)[C@@H]%20O)O[C@@H](n%20ccc(N)nc%20=O)[C@@H]%19O)O[C@@H](n%19ccc(=O)[nH]c%19=O)[C@@H]%18O)O[C@@H](n%18ccc(N)nc%18=O)[C@@H]%17O)O[C@@H](n%17cnc%18c(N)ncnc%18%17)[C@@H]%16O)O[C@@H](n%16ccc(N)nc%16=O)[C@@H]%15O)O[C@@H](n%15ccc(N)nc%15=O)[C@@H]%14O)O[C@@H](n%14cnc%15c(N)ncnc%15%14)[C@@H]%13O)O[C@@H](n%13cnc%14c(N)ncnc%14%13)[C@@H]%12O)O[C@@H](n%12cnc%13c(=O)[nH]c(N)nc%13%12)[C@@H]%11O)O[C@@H](n%11cnc%12c(=O)[nH]c(N)nc%12%11)[C@@H]%10O)O[C@@H](n%10ccc(N)nc%10=O)[C@@H]9O)O[C@@H](n9ccc(N)nc9=O)[C@@H]8O)O[C@@H](n8cnc9c(N)ncnc98)[C@@H]7O)O[C@@H](n7cnc8c(=O)[nH]c(N)nc87)[C@@H]6O)O[C@@H](n6ccc(N)nc6=O)[C@@H]5O)O[C@@H](n5cnc6c(N)ncnc65)[C@@H]4O)O[C@@H](n4ccc(N)nc4=O)[C@@H]3O)O2)c(=O)[nH]c1=O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]","inchiKey":"JKXXLIACMWFHSH-FIIWBELYSA-A","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"BEVASIRANIB SODIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2110581","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bevasiranib sodium","CAND5"],"description":"Oligonucleotide drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2103867","canonicalSmiles":"CC(C)C[C@H](NC(=O)[C@@H]1CSSC[C@@H]2NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CC(N)=O)CSSC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC2=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N1)C(=O)O","inchiKey":"NSPHQWLKCGGCQR-DLJDZFDSSA-N","drugType":"Protein","blackBoxWarning":true,"name":"PLECANATIDE","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Trulance"],"synonyms":["Guanilib","Plecanatide","SP-304","SP-304 (SYNERGY)"],"crossReferences":{"drugbank":["DB13170"]},"linkedTargets":{"rows":["ENSG00000070019"],"count":1},"linkedDiseases":{"rows":["EFO_0000555","HP_0002019"],"count":2},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for constipation and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2104461","canonicalSmiles":"O=C1CN2CCOC2(c2ccccc2F)c2cc(Br)ccc2N1","inchiKey":"XDKCGKQHVBOOHC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HALOXAZOLAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Haloxazolam","Somelin"],"crossReferences":{"drugbank":["DB01476"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105634","canonicalSmiles":"CO[C@]1(C(=O)N[C@@H]2CC[C@@]3(C)[C@@H](CC[C@@H]4[C@@H]3CC[C@@]3(C)[C@H]4CC[C@@H]3[C@H](C)CCCC(C)C)C2)C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O1","inchiKey":"CHMRTBYTCBDIRG-JQZMMWJVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"COLENEURAMIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Coleneuramide","MCC-257"],"crossReferences":{"drugbank":["DB14932"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2107027","canonicalSmiles":"O=C([O-])CCCCCCCNC(=O)c1ccccc1O.[Na+]","inchiKey":"UOENJXXSKABLJL-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SALCAPROZATE SODIUM","maximumClinicalTrialPhase":1,"parentId":"CHEMBL16503","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E-414","E414","SNAC","Salcaprozate sodium"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108359","drugType":"Antibody","blackBoxWarning":false,"name":"NIMOTUZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Theraloc theracim"],"synonyms":["HR3","Nimotuzumab","OSAG 101","THERACIM-HR3","THERALOC"],"linkedTargets":{"rows":["ENSG00000146648"],"count":1},"linkedDiseases":{"rows":["EFO_1000172","EFO_0002938","EFO_1000657","MONDO_0007254","EFO_0004252","EFO_0000228","EFO_1001951","MONDO_0001056","MONDO_0002974","MONDO_0008903","EFO_0000326","EFO_0000707","EFO_0002618","EFO_0003897","EFO_0000616","EFO_0006859","EFO_0005922","EFO_1001931","EFO_0002916","EFO_0005842","MONDO_0007576","EFO_0000313","EFO_0003060","MONDO_0002914","EFO_0000311","EFO_1000026","EFO_0001061","EFO_0000199","MONDO_0001325","EFO_0000181","EFO_0000519"],"count":31},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 29 investigational indications."}
{"id":"CHEMBL2108615","drugType":"Cell","blackBoxWarning":false,"name":"LAPULEUCEL-T","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Neuvenge"],"synonyms":["APC-8024","APC8024","Dn24-02","Lapuleucel-t"],"description":"Cell drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109072","drugType":"Unknown","blackBoxWarning":false,"name":"FIBRINOGEN, HUMAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Fibrogen"],"synonyms":["Evarrest","Factor i (fibrinogen)","Factor i human","Fibrinogen","Fibrinogen (human)","Fibrinogen concentrate (human)","Fibrinogen concentrate human","Fibrinogen human","Fibrinogen human plasma-derived","Fibrinogen, human","Human fibrinogen","Parenogen","Raplixa"],"linkedTargets":{"rows":["ENSG00000171560","ENSG00000171564","ENSG00000171557"],"count":3},"linkedDiseases":{"rows":["EFO_0002618","EFO_0003777","EFO_0005207","EFO_0009579","Orphanet_335","EFO_0000546","MP_0001914","EFO_0010282","HP_0001871","MONDO_0000831","EFO_0001421","HP_0011900","EFO_0009314","HP_0031273","MONDO_0005178","HP_0002647"],"count":16},"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL2109367","drugType":"Antibody","blackBoxWarning":false,"name":"LMB-2","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LMB-2","Lmb-2"],"linkedTargets":{"rows":["ENSG00000134460"],"count":1},"linkedDiseases":{"rows":["EFO_0000565","MONDO_0019471","EFO_1000956","EFO_0000574"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2109443","drugType":"Antibody","blackBoxWarning":false,"name":"F105","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["F105"],"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109644","drugType":"Antibody","blackBoxWarning":false,"name":"TNT-1B","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Cotara"],"synonyms":["TNT-1B","Tnt-1b"],"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2110651","canonicalSmiles":"C[N+]1(CCC(O)(c2ccccc2)c2cccs2)CCOCC1","inchiKey":"HJDYAOBDPZQHOD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIEMONIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tiemonium cation","Tiemonium ion"],"childChemblIds":["CHEMBL2104797"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2111081","canonicalSmiles":"Cc1sc[n+](CC(=O)c2ccccc2)c1C","inchiKey":"LYLFQLCLUXOFOL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALAGEBRIUM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alagebrium","Alagebrium cation","Alagebrium ion"],"crossReferences":{"drugbank":["DB12497"]},"childChemblIds":["CHEMBL2107309"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2152047","canonicalSmiles":"O=C(O)[C@H](O)[C@@H](O)CO","inchiKey":"JPIJQSOTBSSVTP-STHAYSLISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"L-THREONIC ACID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-threonate","L-threonic acid","Threonate","Threonic acid, l-"],"crossReferences":{"drugbank":["DB11192"],"chEBI":["15908"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2158685","canonicalSmiles":"O=C(NCc1ccncc1)C12CC3CC(C1)CC(c1ccc(Cl)cc1)(C3)C2","inchiKey":"CAOTVXGYTWCKQE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABC-294640","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABC 294640","Abc-294640","Abc294640","Opaganib"],"crossReferences":{"PubChem":["174006706"],"drugbank":["DB12764"]},"linkedTargets":{"rows":["ENSG00000063176"],"count":1},"linkedDiseases":{"rows":["EFO_0002618","EFO_0000182","EFO_0000403","EFO_0001378","MONDO_0008315","EFO_0005221"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2170582","canonicalSmiles":"CNC(=O)COc1cccc(Nc2ncc(F)c(Nc3ccc4c(c3)NC(=O)C(F)(F)O4)n2)c1","inchiKey":"MOXXQFNQDDSJHT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"R-343","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL3545340"],"linkedTargets":{"rows":["ENSG00000165025"],"count":1},"linkedDiseases":{"rows":["MONDO_0004979"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL219376","canonicalSmiles":"O=C(O)c1c(O)c(-c2ccccc2)nc2ccccc12","inchiKey":"XAPRFLSJBSXESP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXYCINCHOPHEN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hydroxycincophene","NSC-41784","Oxicinchophen","Oxycinchopen","Oxycinchophen"],"crossReferences":{"PubChem":["170466564"],"drugbank":["DB13596"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL221572","canonicalSmiles":"NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O)[C@H]2O[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)[C@H](N)[C@@H](O)[C@@H]1O","inchiKey":"NSKGQURZWSPSBC-VVPCINPTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIBOSTAMYCIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-138925","Ribostamycin","Ribostamycin sulfate"],"crossReferences":{"drugbank":["DB03615"],"chEBI":["45257"]},"childChemblIds":["CHEMBL3138633"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL238502","canonicalSmiles":"CCCCCCC(N)=O","inchiKey":"AEDIXYWIVPYNBI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HEPTANAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Octanoylamide"],"crossReferences":{"drugbank":["DB02641"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL242469","canonicalSmiles":"C[C@@]1(C(=O)Nc2ccc(C#N)c(C(F)(F)F)c2)CC(C(F)(F)F)=NN1","inchiKey":"RYBKPGYFXRNMMU-LBPRGKRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL242469","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13936"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL243580","canonicalSmiles":"c1ccc2c(c1)[nH]c1ccccc12","inchiKey":"UJOBWOGCFQCDNV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["9H-Carbazole","Carbazole"],"crossReferences":{"PubChem":["144208901","144213164","17389991","26752943","47193682"],"Wikipedia":["Carbazole"],"drugbank":["DB07301"],"chEBI":["27543"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL253896","canonicalSmiles":"COc1cc(O)c(CC=C(C)C)c(O)c1C(=O)/C=C/c1ccc(O)cc1","inchiKey":"ORXQGKIUCDPEAJ-YRNVUSSQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"XANTHOHUMOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Xantho-flav","Xanthohumol"],"crossReferences":{"Wikipedia":["Xanthohumol"],"drugbank":["DB15359"],"chEBI":["66331"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL256087","canonicalSmiles":"CC1CCC(C(C)C)C(O)C1","inchiKey":"NOOLISFMXDJSKH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MENTHOL","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aqua-cool","Aquasoothe","Arjun","Catarrh","Dermacool","Fisherman's friend lozenges","Halls","Karvol","Lockets","Meggezones","Muirs","Therapeutic mineral ice","Tixylix decongestant inh","Vocalzone"],"synonyms":["Dl-menthol","FEMA NO. 2665","Menthol","Menthol racemate","NSC-2603","Racementhol"],"crossReferences":{"PubChem":["144207208","144213774","26754473","29215309"],"chEBI":["25187"]},"linkedTargets":{"rows":["ENSG00000144481","ENSG00000104321"],"count":2},"linkedDiseases":{"rows":["HP_0000155","HP_0000989","HP_0012735","EFO_0009846","EFO_0003768","HP_0002829","EFO_1000783","MONDO_0001056","EFO_1001347","MONDO_0002471","EFO_0009582","EFO_0009552","HP_0002015","HP_0000737","MONDO_0021201","EFO_0005856","EFO_0003958","EFO_0009661","EFO_0009516","HP_0003418","HP_0003394","HP_0001742","EFO_0003843","HP_0002315","EFO_0007214","EFO_1000941","EFO_0000537","EFO_0002496","EFO_0000546","EFO_0009866","HP_0003326","MONDO_0100096","EFO_0004517","MONDO_0004979","MONDO_0002258","MONDO_0005178","EFO_1001434","MONDO_0004857"],"count":38},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and has 28 approved and 5 investigational indications."}
{"id":"CHEMBL264669","canonicalSmiles":"c1ccc(NCc2cccnc2)cc1","inchiKey":"BJXLHKJBRORJJJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL264669","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["14725365"],"drugbank":["DB06851"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL273481","canonicalSmiles":"NCc1cc(O)no1","inchiKey":"ZJQHPWUVQPJPQT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MUSCIMOL","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Agarin","Muscimol","NSC-333569","Pantherine"],"crossReferences":{"PubChem":["11111210","11113437","90341084"],"Wikipedia":["Muscimol"],"drugbank":["DB12458"],"chEBI":["7035"]},"childChemblIds":["CHEMBL1256363"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL276864","canonicalSmiles":"NCCCc1ccccc1","inchiKey":"LYUQWQRTDLVQGA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3-Phenyl-Propylamine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3-Phenyl-Propylamine","3-Phenylpropylamine"],"crossReferences":{"drugbank":["DB04410"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL278462","canonicalSmiles":"CC(C)(C)CCC#C[C@@H]1C[C@H]1c1c[nH]cn1","inchiKey":"CVKJAXCQPFOAIN-VXGBXAGGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CIPRALISANT","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-)-GT-2331","Cipralisant","Cipralisant, (-)-","GT-2331"],"crossReferences":{"Wikipedia":["Cipralisant"]},"childChemblIds":["CHEMBL2106003"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL288010","canonicalSmiles":"CC(C)CCN(C[C@@H](O)[C@@H]1Cc2ccc(cc2)OCCCC(=O)N[C@@H](C(C)C)C(=O)N1)S(=O)(=O)c1ccccc1","inchiKey":"WRUVOSYKHXGAQN-GKRYNVPLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL288010","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03768"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL298406","canonicalSmiles":"CN1CCc2cc(Cl)c(O)cc2[C@H]2c3ccccc3CC[C@@H]21","inchiKey":"DMJWENQHWZZWDF-PKOBYXMFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ECOPIPAM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ecopipam","SCH-39166"],"crossReferences":{"PubChem":["144204748","170466462"],"drugbank":["DB12273"]},"childChemblIds":["CHEMBL1535402","CHEMBL1822916"],"linkedTargets":{"rows":["ENSG00000184845"],"count":1},"linkedDiseases":{"rows":["Orphanet_510","EFO_0004895","EFO_0004699","EFO_0004270","MONDO_0002182","EFO_0009878"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL298734","canonicalSmiles":"NC(=O)N1CCC(CC(=O)N2CCC([C@H]3c4ncc(Br)cc4CCc4cc(Cl)cc(Br)c43)CC2)CC1","inchiKey":"DHMTURDWPRKSOA-RUZDIDTESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LONAFARNIB","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Zokinvy"],"synonyms":["Lonafarnib","SCH 66336","SCH-66336","SCH66336","Sarasar"],"crossReferences":{"Wikipedia":["Lonafarnib"],"drugbank":["DB06448"]},"linkedTargets":{"rows":["ENSG00000168522","ENSG00000257365"],"count":2},"linkedDiseases":{"rows":["EFO_0000198","EFO_1001779","EFO_0006859","MONDO_0004192","MONDO_0008170","EFO_1001465","MONDO_0007254","Orphanet_740","EFO_0007304","EFO_0003060","MONDO_0020654","MONDO_0001187","EFO_0009708","EFO_1001951","MONDO_0002691","EFO_0000339","MONDO_0020732","EFO_0000574","EFO_0002499","MONDO_0024880","EFO_1000158"],"count":21},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and is indicated for hutchinson-gilford progeria syndrome and progeria and has 17 investigational indications."}
{"id":"CHEMBL311300","canonicalSmiles":"Nc1nc2c(Cc3cccnc3)c[nH]c2c(=O)[nH]1","inchiKey":"DOHVAKFYAHLCJP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PELDESINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BCX-34","Peldesine"],"crossReferences":{"drugbank":["DB02568"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3182733","canonicalSmiles":"CCCN[C@H]1CCc2nc(N)sc2C1.Cl.Cl.O","inchiKey":"APVQOOKHDZVJEX-QTPLPEIMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRAMIPEXOLE DIHYDROCHLORIDE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL301265","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mirapex","Mirapex Extended Release","Mirapex er","Pramipexole dihydrochloride"],"synonyms":["Daquiran","PNU-98528E","Pramipexole accord","Pramipexole dihydrochloride","Pramipexole dihydrochloride anhydrous","Pramipexole dihydrochloride monohydrate","Pramipexole hydrochloride","Pramipexole hydrochloride hydrate","Pramipexole teva","SND-919CL2Y","SND919CL2Y","Sifrol"],"crossReferences":{"DailyMed":["pramipexole%20dihydrochloride"],"PubChem":["144212633"],"chEBI":["51147"]},"linkedTargets":{"rows":["ENSG00000149295","ENSG00000069696","ENSG00000151577"],"count":3},"linkedDiseases":{"rows":["EFO_0000289","MONDO_0005180","MONDO_0004976","EFO_0004270"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and is indicated for restless legs syndrome and parkinson disease and has 2 investigational indications."}
{"id":"CHEMBL3287218","canonicalSmiles":"Cc1cc(-c2ccc3c(c2)CC[C@H]3N2CC3(CCN(C(=O)Cc4cn5cc(C)sc5n4)CC3)C2)ncn1","inchiKey":"ZIUDADZJCKGWKR-AREMUKBSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-5190457","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-5190457","Pf-05190457","Pf-5190457"],"crossReferences":{"drugbank":["DB14870"]},"linkedTargets":{"rows":["ENSG00000121853"],"count":1},"linkedDiseases":{"rows":["MONDO_0021698","EFO_0004329","MONDO_0007079","MONDO_0005148"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3304244","canonicalSmiles":"Cc1nn(-c2ncccc2CO)cc1CN1CCC2(CC1)OCC(F)(F)c1cc(Cl)sc12","inchiKey":"NKQHBJNRBKHUQR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LY-2940094","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BTRX-246040","Btrx-246040","J3.309.394B","Ly-2940094"],"childChemblIds":["CHEMBL3236487"],"linkedTargets":{"rows":["ENSG00000125510"],"count":1},"linkedDiseases":{"rows":["MONDO_0002009","MONDO_0005180"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3544930","drugType":"Small molecule","blackBoxWarning":false,"name":"SC-80036","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sc-80036"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545132","drugType":"Antibody","blackBoxWarning":false,"name":"MIRVETUXIMAB SORAVTANSINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IMGN-853","IMGN853","Mirvetuximab soravtansine"],"linkedTargets":{"rows":["ENSG00000261456","ENSG00000167553","ENSG00000127824","ENSG00000188229","ENSG00000198033","ENSG00000258947","ENSG00000110195","ENSG00000152086","ENSG00000196230","ENSG00000104833","ENSG00000167552","ENSG00000137267","ENSG00000101162","ENSG00000137285","ENSG00000123416","ENSG00000176014"],"count":16},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0002158","EFO_1000238","MONDO_0015686","MONDO_0008170","MONDO_0011962","EFO_1000231","MONDO_0007254","EFO_0000305"],"count":9},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL3545376","canonicalSmiles":"COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1","inchiKey":"OLAHOMJCDNXHFI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERDAFITINIB","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Balversa"],"synonyms":["Erdafitinib","JNJ-42756493","Jnj-42756493"],"crossReferences":{"DailyMed":["erdafitinib"],"drugbank":["DB12147"]},"childChemblIds":["CHEMBL3918638","CHEMBL3919709","CHEMBL3975791","CHEMBL3948043"],"linkedTargets":{"rows":["ENSG00000066468","ENSG00000068078","ENSG00000077782","ENSG00000160867"],"count":4},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0007254","EFO_0000708","EFO_0003060","MONDO_0001187","EFO_0000311","EFO_0000294","EFO_0003863","EFO_0001421","EFO_0000182","EFO_0008528","EFO_0000574","EFO_0000673","EFO_0000196","EFO_0001378"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and has 5 approved and 10 investigational indications."}
{"id":"CHEMBL3545381","drugType":"Small molecule","blackBoxWarning":false,"name":"PLX-7486","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Plx-7486"],"linkedTargets":{"rows":["ENSG00000140538","ENSG00000182578","ENSG00000148053","ENSG00000198400"],"count":4},"linkedDiseases":{"rows":["MONDO_0002171"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL359164","canonicalSmiles":"Nc1ccn([C@@H]2CO[C@H](CO)O2)c(=O)n1","inchiKey":"RXRGZNYSEHTMHC-BQBZGAKWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TROXACITABINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-)-ODDC","BCH-4556","Lamivudine impurity i","Lamivudine impurity i rs","Troxacitabine","Troxatyl"],"crossReferences":{"Wikipedia":["Troxacitabine"],"drugbank":["DB04961"]},"linkedTargets":{"rows":["ENSG00000177084","ENSG00000101868","ENSG00000146143","ENSG00000062822","ENSG00000148229","ENSG00000198056","ENSG00000100479","ENSG00000077514","ENSG00000106628","ENSG00000014138","ENSG00000175482"],"count":11},"linkedDiseases":{"rows":["EFO_0000565","EFO_0000616","EFO_0000222"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3621988","canonicalSmiles":"Nc1cc(F)ccc1NC(=O)c1ccc(CNC(=O)/C=C/c2cccnc2)cc1","inchiKey":"SZMJVTADHFNAIS-BJMVGYQFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TUCIDINOSTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Epidaza in china"],"synonyms":["CS-055","CS055","Chidamide","Epidaza","HBI-8000","Tucidinostat"],"crossReferences":{"drugbank":["DB06334"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 27 investigational indications."}
{"id":"CHEMBL367463","canonicalSmiles":"CC(C(=O)O)c1ccc2c(c1)Cc1cccnc1O2","inchiKey":"TVQZAMVBTVNYLA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRANOPROFEN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Elicapric","NSC-759832","Pranoprofen","Pyranoprofen"],"crossReferences":{"PubChem":["144206154","170465811","50113024"],"Wikipedia":["Pranoprofen"],"drugbank":["DB13514"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3707284","drugType":"Small molecule","blackBoxWarning":false,"name":"FERRIC SODIUM CITRATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ferric sodium citrate","Sodium ferric citrate","Sodium ferricitrate complex"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3707317","drugType":"Small molecule","blackBoxWarning":false,"name":"LOREDIPLON","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gf-015535-00","Lorediplon"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707331","canonicalSmiles":"C[C@@H](OC[C@@]1(c2ccccc2)CC[C@]2(CCC(=O)N2)CN1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1","inchiKey":"FIVSJYGQAIEMOC-ZGNKEGEESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROLAPITANT","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Varuby"],"synonyms":["Rolapitant"],"crossReferences":{"DailyMed":["rolapitant%20hydrochloride"],"drugbank":["DB09291"]},"childChemblIds":["CHEMBL3707330"],"linkedTargets":{"rows":["ENSG00000115353"],"count":1},"linkedDiseases":{"rows":["EFO_0006911","EFO_0004888","EFO_0000691","HP_0002018"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and is indicated for chemotherapy-induced nausea and vomiting and nausea and has 2 investigational indications."}
{"id":"CHEMBL3707371","canonicalSmiles":"CC(CN1c2ccccc2Sc2ccccc21)[N+](C)(C)CCO","inchiKey":"PDSVTRQOBUIQBQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROXYETHYLPROMETHAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hydroxyethylpromethazine","N-hydroxyethylpromethazine","Promethazine hydroxyethyl"],"crossReferences":{"drugbank":["DB13840"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL37853","canonicalSmiles":"O=C(O)CCC/C=C\\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)COc1cccc(Cl)c1","inchiKey":"VJGGHXVGBSZVMZ-QIZQQNKQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOPROSTENOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["29217531"],"drugbank":["DB11507"]},"childChemblIds":["CHEMBL1520583"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL379652","canonicalSmiles":"OCCCO","inchiKey":"YPFDHNVEDLHUCE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"1,3-PROPANEDIOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1,3-Propanediol"],"crossReferences":{"PubChem":["144211067"],"Wikipedia":["1,3-Propanediol"],"drugbank":["DB02774"],"chEBI":["16109"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL383208","canonicalSmiles":"N[C@@H](CC1CCCCC1)C(=O)O","inchiKey":"ORQXBVXKBGUSBA-QMMMGPOBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL383208","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02884"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL392158","canonicalSmiles":"C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCF)cc(OC)c1OC","inchiKey":"OABRYNHZQBZDMG-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FALLYPRIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fallypride"],"crossReferences":{"drugbank":["DB15167"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3975308","canonicalSmiles":"CC(C)(O)[C@H]1CC[C@H](Nc2ccc3ncc(-c4cccc(C(F)(F)F)c4)n3n2)CC1","inchiKey":"XRNVABDYQLHODA-JCNLHEQBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TP-3654","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SGI-9481","TP-3654","Tp-3654"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3989521","canonicalSmiles":"CC(C)NCC(O)c1ccc(O)c(O)c1.CC(C)NCC(O)c1ccc(O)c(O)c1.O.O.O=S(=O)(O)O","inchiKey":"CUQPTVCVZLUXJB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOPROTERENOL SULFATE","yearOfFirstApproval":1956,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL434","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Medihaler-iso","Norisodrine"],"synonyms":["Aludrin","Isomist","Isoprenaline sulfate","Isoprenaline sulfate dihydrate","Isoprenaline sulphate","Isoprenalini sulfas","Isopropylarterenol sulfate","Isoproterenol sulfate","Isoproterenol sulfate dihydrate","Isoproterenol sulphate","Propal"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1956."}
{"id":"CHEMBL3989961","canonicalSmiles":"CCN(CC)C(=O)COC(=O)/C=C/C(=O)OC","inchiKey":"AKUGRXRLHCCENI-VOTSOKGWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEPILAMIDE FUMARATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PPC-06","Tepilamide fumarate","XP-23829","XP23829"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4068509","canonicalSmiles":"C=CC(=O)N1CCN(CCCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)CC1","inchiKey":"PUIXMSRTTHLNKI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRN-1371","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Prn-1371"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL413654","canonicalSmiles":"CSCC[C@@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@@H](C)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H](N)CCC(=O)O)C(=O)N[C@H](CC(=O)O)C(=O)N[C@H](Cc1ccccc1)C(N)=O","inchiKey":"AOXOCDRNSPFDPE-UKEONUMOSA-N","drugType":"Protein","blackBoxWarning":false,"name":"GASTRIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gastrin"],"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL419","canonicalSmiles":"NCc1ccc(S(N)(=O)=O)cc1","inchiKey":"TYMRLRRVMHJFTF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MAFENIDE","yearOfFirstApproval":1969,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sulfamylon"],"synonyms":["4-homosulfanilamide","D06BA03","Mafenide","NSC-34632"],"crossReferences":{"DailyMed":["mafenide%20acetate"],"PubChem":["11112297"],"Wikipedia":["Mafenide"],"drugbank":["DB06795"],"chEBI":["6633"]},"childChemblIds":["CHEMBL1201161","CHEMBL1593568"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1969 and is indicated for burn and bacterial disease and has 1 investigational indication."}
{"id":"CHEMBL4297202","drugType":"Small molecule","blackBoxWarning":false,"name":"BIXALOMER","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG-223","ASP-1585","ASP1585","Asp1585","Bixalomer","ILY-101","ILY101","Ily101","Kiklin"],"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL4297232","drugType":"Unknown","blackBoxWarning":false,"name":"DICLOFENAC ETALHYALURONATE SODIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diclofenac etalhyaluronate sodium","SI-613 SODIUM"],"description":"Unknown drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297299","canonicalSmiles":"O=C(Cc1ccc(-c2ccc(N3CCOCC3)cc2)cn1)NCc1cccc(F)c1","inchiKey":"CMKKPJNMYLOUCE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"KX2-361","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KX-02","KX-2361","Kx2-361"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297358","canonicalSmiles":"CC(C)C[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)CN)C(=O)N[C@H](C(=O)O)C(C)C","inchiKey":"HEEWEZGQMLZMFE-RKGINYAYSA-N","drugType":"Protein","blackBoxWarning":false,"name":"BPC-157","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bepecin","Bpc-157","PL-10","PL-14736","PLD-116"],"crossReferences":{"drugbank":["DB11882"]},"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297480","canonicalSmiles":"O=C(Nc1ccc(F)cc1)c1cnc(SCc2cc(OC(F)(F)F)ccc2B(O)O)nc1","inchiKey":"SDUDZBCEHIZMFZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SX-682","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SX-682","Sx-682"],"linkedTargets":{"rows":["ENSG00000180871","ENSG00000163464"],"count":2},"linkedDiseases":{"rows":["EFO_0000198","EFO_1001480","EFO_0000756","EFO_0002517","EFO_1000657","MONDO_0024880","EFO_1001949"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4297632","canonicalSmiles":"COCCOCCOCCOCCOCCOCCO[C@H]1CCC2(O)[C@H]3Cc4ccc(OC)c5c4[C@@]2(CCN3C)[C@H]1O5","inchiKey":"RQHILGKAOIGUHU-BUCMUWKRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXYCODEGOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Loxicodegol","NKTR-181","Nktr-181","Oxicodegol","Oxycodegol"],"childChemblIds":["CHEMBL4298154"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["HP_0012532","EFO_0004616","HP_0003419"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297682","drugType":"Unknown","blackBoxWarning":false,"name":"ABBV-257","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Abbv-257"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297701","drugType":"Unknown","blackBoxWarning":false,"name":"BIO-11006","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIO-11006","Bio-11006"],"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297728","drugType":"Antibody","blackBoxWarning":false,"name":"CIRMTUZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cirmtuzumab","UC-961","Zilovertamab"],"linkedTargets":{"rows":["ENSG00000185483"],"count":1},"linkedDiseases":{"rows":["EFO_0002618","MONDO_0001056","EFO_0000096","EFO_0000095","EFO_0005537","MONDO_0008170","EFO_0000403","EFO_0003060","MONDO_0008315"],"count":9},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297836","drugType":"Unknown","blackBoxWarning":false,"name":"TAK-573","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Modakafusp alfa","TAK-573","TEV-48573","Tak-573"],"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297842","drugType":"Antibody","blackBoxWarning":false,"name":"TOMUZOTUXIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tomuzotuximab"],"linkedTargets":{"rows":["ENSG00000146648"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000707"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297922","drugType":"Unknown","blackBoxWarning":false,"name":"TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 9","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-1bb ligand receptor","Cd137","Cdw137","T-cell antigen 4-1bb homolog","T-cell antigen ila","Tnfrsf9","Tumor necrosis factor receptor superfamily member 9"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297927","drugType":"Unknown","blackBoxWarning":false,"name":"LUMEFANTRINE CO-ARTEMETHER","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CPG-56697","Coartem","Lumefantrine co-artemether","Riamet"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4298172","canonicalSmiles":"O=C(c1cccnc1-c1ccncc1)N1CCC(O)(Cc2ccccc2)CC1","inchiKey":"XKUZMIUSBMCVPP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SOTICLESTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["OV-935","OV935","Soticlestat","TAK-935"],"linkedTargets":{"rows":["ENSG00000036530"],"count":1},"linkedDiseases":{"rows":["EFO_1001998","EFO_0000474","Orphanet_33069","HP_0200134","EFO_0001421","Orphanet_2382"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4298212","drugType":"Antibody","blackBoxWarning":false,"name":"RAVAGALIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABBV-323","PR-1629977","Ravagalimab"],"linkedTargets":{"rows":["ENSG00000102245"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","EFO_0000699"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4301491","canonicalSmiles":"C=CCc1c(OC(=O)N2CCC(N3CCCCC3)CC2)ccc2nc3c(cc12)Cn1c-3cc2c(c1=O)COC(=O)[C@]2(O)CC","inchiKey":"XPVBLGRILRVSLF-UMSFTDKQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SIMMITECAN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL4297325"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL434492","canonicalSmiles":"COCCOC[C@H](CC1(C(=O)N[C@H]2CC[C@@H](C(=O)O)CC2)CCCC1)C(=O)O","inchiKey":"ACZWIDANLCXHBM-HRCADAONSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CANDOXATRILAT","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Candoxatril diacid","Candoxatrilat","UK-73,967","UK-73967"],"crossReferences":{"drugbank":["DB11623"],"chEBI":["3354"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL45","canonicalSmiles":"COc1ccc2[nH]cc(CCNC(C)=O)c2c1","inchiKey":"DRLFMBDRBRZALE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MELATONIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Circadin","General nutrit","Health aid","Heidadouppi","Icenia","Life ext","Melapure","Natrol","Nature's blend","Natures bounty","Quality health","S.gard","Travelag","Vespro","Vytalonin"],"synonyms":["5-methoxy n-acetyl-tryptamine","BCI-049","J5.258B","Melatol","Melatonin","Melatonine","Melovine","N-(2-(5-Methoxy-1H-Indol-3-Yl)Ethyl)Acetamide","N-Acetyl-5-Methoxytryptamine","NSC-113928","NSC-302012","NSC-56423","Regulin","Tartrol"],"crossReferences":{"PubChem":["104171188","105815","11111468","124880734","124880739","144208725","144213243","170465589","17388930","17389536","26747238","26752764","46500483","50105414","85231137","90340716"],"Wikipedia":["Melatonin"],"drugbank":["DB01065"],"chEBI":["16796"]},"linkedTargets":{"rows":["ENSG00000168412","ENSG00000134640"],"count":2},"linkedDiseases":{"rows":["EFO_0005547","EFO_0000729","MONDO_0002009","EFO_0000275","EFO_0000555","EFO_0000756","EFO_0003768","HP_0031217","EFO_0004698","HP_0000938","HP_0100543","HP_0040187","EFO_1000824","HP_0012378","EFO_0003940","EFO_0000400","MONDO_0002635","EFO_1001904","EFO_0003888","EFO_0003756","EFO_0002687","HP_0001919","EFO_0003758","EFO_0000701","EFO_0009516","Orphanet_2382","EFO_0001666","EFO_0000660","HP_0100806","MP_0001914","EFO_0000546","MONDO_0100096","EFO_0005800","EFO_0007282","MONDO_0005090","EFO_0004723","EFO_0005687","MONDO_0024290","HP_0000726","EFO_1001905","MONDO_0007254","EFO_0009267","EFO_0008568","EFO_0000274","EFO_0000495","EFO_0009579","EFO_0003948","MONDO_0005277","EFO_0000474","EFO_0000289","MONDO_0002050","MONDO_0021698","EFO_1001216","MONDO_0005180","MONDO_0005299","EFO_0003917","EFO_0005230","EFO_0007462","EFO_0000616","EFO_0000280","EFO_0006859","EFO_0003928","EFO_0000545","HP_0002140","EFO_0003958","EFO_0003929","EFO_0003843","EFO_0003060","EFO_0002615","EFO_0000311","HP_0000713","EFO_0000537","EFO_0000195","EFO_0000589","MONDO_0001134","HP_0002172","MONDO_0005301","EFO_0003854","EFO_0000649","EFO_1001121","EFO_0001421","EFO_0000199","EFO_0008583","EFO_0003918","MONDO_0024880","EFO_0005411"],"count":86},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 61 investigational indications."}
{"id":"CHEMBL4577523","canonicalSmiles":"COc1nn(C)cc1Nc1nccc(-c2c[nH]c3c(NC(=O)[C@@H](C)N4CCN(C)CC4)cccc23)n1","inchiKey":"CVCVOSPZEVINRM-MRXNPFEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD4205","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-4205","AZD4205","Azd4205","Golidocitinib"],"linkedTargets":{"rows":["ENSG00000162434"],"count":1},"linkedDiseases":{"rows":["EFO_0000211","EFO_0003060"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594311","drugType":"Gene","blackBoxWarning":false,"name":"BETIBEGLOGENE AUTOTEMCEL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BB-305","Betibeglogene autotemcel","LentiGlobin BB305","Zynteglo"],"linkedTargets":{"rows":["ENSG00000244734"],"count":1},"linkedDiseases":{"rows":["Orphanet_232","Orphanet_848","Orphanet_231214"],"count":3},"description":"Gene drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4650230","canonicalSmiles":"CN1CCC2(CC1)NCC(=O)N2Cc1ccccc1","inchiKey":"BSQPTZYKCAULBH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SIMUFILAM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Filora"],"synonyms":["C-0105","C0105","C0105M","PTI-125","PTI-910","Simufilam"],"childChemblIds":["CHEMBL4650231"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4802220","drugType":"Antibody","blackBoxWarning":false,"name":"BELUDAVIMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Beludavimab","VIR-7832","Vir-7832"],"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL490665","canonicalSmiles":"CN(C(=O)/C=C/c1ccoc1)[C@@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5.Cl","inchiKey":"DJSFYNINGIMKAG-FQJQBBMWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NALFURAFINE HYDROCHLORIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL267495","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nalfurafine hcl","Nalfurafine hydrochloride","Nopicor","Remitch","TRK-820"],"linkedTargets":{"rows":["ENSG00000082556"],"count":1},"linkedDiseases":{"rows":["EFO_0001421","EFO_0003884"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL504535","canonicalSmiles":"CCCN1CC(c2ccc(S(C)(=O)=O)cc2)=C(c2ccc(C)cc2)C1=O","inchiKey":"AXMZZGKKZDJGAZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IMRECOXIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAP-909","Imrecoxib"],"crossReferences":{"drugbank":["DB12354"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL522892","canonicalSmiles":"CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1","inchiKey":"PIQCTGMSNWUMAF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOVITINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CHIR-258","Dovitinib","GFKI-258","NVP-TKI258","TKI-258","Tki-258"],"crossReferences":{"PubChem":["103904684","137275871","50100092"],"drugbank":["DB05928"]},"childChemblIds":["CHEMBL4297063"],"linkedTargets":{"rows":["ENSG00000134853","ENSG00000128052","ENSG00000068078","ENSG00000102755","ENSG00000037280","ENSG00000113721","ENSG00000157404","ENSG00000122025"],"count":8},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0002108","EFO_0000756","EFO_0000681","EFO_0000349","Orphanet_44890","EFO_1001465","MONDO_0007254","EFO_0000222","MONDO_0008315","EFO_0000231","EFO_0003060","EFO_0000311","MONDO_0001187","Orphanet_892","EFO_0003863","MONDO_0001056","EFO_1000044","EFO_0000770","EFO_0002517","MONDO_0011962","EFO_0000182","EFO_0001378","EFO_1000796","EFO_0000519"],"count":25},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 25 investigational indications."}
{"id":"CHEMBL53904","canonicalSmiles":"OCCN1CCN(CC/C=C2/c3ccccc3Sc3ccc(Cl)cc32)CC1","inchiKey":"WFPIAZLQTJBIFN-DVZOWYKESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZUCLOPENTHIXOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Clopenthixol","Clopenthixol cis(z)-form","Clopixol","Zuclopenthixol"],"crossReferences":{"Wikipedia":["Zuclopenthixol"],"drugbank":["DB01624"],"chEBI":["51364"]},"childChemblIds":["CHEMBL2360084","CHEMBL1437855"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL551813","canonicalSmiles":"CN(C)c1nc(Cc2ccc(NC(=O)c3ccc(C(F)(F)F)cc3)cc2)nc(N(C)C)c1CC(=O)O","inchiKey":"XEOSTBFUCNZKGS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BI-671800","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Actimis","BI 671800","Bi 671800","Bi-671800"],"crossReferences":{"PubChem":["174006824"],"drugbank":["DB12524"]},"linkedTargets":{"rows":["ENSG00000183134"],"count":1},"linkedDiseases":{"rows":["MONDO_0004979"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL563","canonicalSmiles":"CC(C(=O)O)c1ccc(-c2ccccc2)c(F)c1","inchiKey":"SYTBZMRGLBWNTM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"FLURBIPROFEN","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ansaid","Cebutid","Flurbiprofen","Froben","Froben sr","Strefen","Transact"],"synonyms":["BTS 18,322","BTS-18322","Flubiprofen","Flurbiprofen","NSC-757037","Ocufen","U-27,182","U-27182"],"crossReferences":{"DailyMed":["flurbiprofen","flurbiprofen%20sodium"],"PubChem":["144204098","144212670","174007327","26747178","49732000","520771","855731","860839"],"Wikipedia":["Flurbiprofen"],"drugbank":["DB00712"],"chEBI":["5130"]},"childChemblIds":["CHEMBL3989754","CHEMBL1200990"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_0000685","EFO_0009657","HP_0003418","EFO_0003843","EFO_0005755","EFO_0003060","HP_0000616","HP_0002829","Orphanet_68380","HP_0003326","EFO_0000649","EFO_0000764","EFO_0004272","HP_0003419","MONDO_0002258","MONDO_0005148","EFO_0005752"],"count":17},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and has 5 approved and 9 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL674","canonicalSmiles":"CCC(CC)O[C@@H]1C=C(C(=O)O)C[C@H](N)[C@H]1NC(C)=O","inchiKey":"NENPYTRHICXVCS-YNEHKIRRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OSELTAMIVIR CARBOXYLATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GS 4071","GS-4071","GS4071","Oseltamivir","Oseltamivir acid","Oseltamivir acid, (-)-","Oseltamivir carboxylate","Oseltamivir free acid","RO-64-0802","RO-640802"],"crossReferences":{"drugbank":["DB02600"],"chEBI":["73139"]},"childChemblIds":["CHEMBL2296412","CHEMBL1956715","CHEMBL252187"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL691","canonicalSmiles":"C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C","inchiKey":"BFPYWIDHMRZLRN-SLHNCBLASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHINYL ESTRADIOL","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Estinyl","Etinestryl","Feminone","Follicoral","Lynoral"],"synonyms":["17-ethinylestradiol","17alpha-ethinylestradiol","Enovid","Enovid-E","Ethinyl Estradiol","Ethinyl estradiol","Ethinylestradiol","Ethinylestradiolum","Ethinyloestradiol","Ethynylestradiol","Ginestrene","NSC-10973","Norinyl","Ovulen","Ovulen-21","Ovulen-28"],"crossReferences":{"DailyMed":["ethinyl%20estradiol"],"PubChem":["144204698","144208489","144210731","170464983","26753042","76025"],"TG-GATEs":["55"],"drugbank":["DB00977"],"chEBI":["4903"]},"linkedTargets":{"rows":["ENSG00000091831"],"count":1},"linkedDiseases":{"rows":["EFO_0005204","EFO_1000710","MONDO_0004169","EFO_0001065","EFO_0009006","EFO_0007453","MONDO_0007254","EFO_1001249","Orphanet_586","EFO_0003882","EFO_0002950","EFO_0005924","HP_0000938","MONDO_0005277","MONDO_0002050","EFO_0003932","EFO_0003047","EFO_0004215","EFO_0000616","EFO_0000685","EFO_0000765","EFO_0000545","EFO_0008560","EFO_0000180","EFO_0009315","EFO_0003894","EFO_0003843","EFO_0000660","Orphanet_3388","EFO_0004239","EFO_0000311","MP_0001914","EFO_0010269","EFO_0004220","EFO_0000095","EFO_0000764","MONDO_0011962","HP_0100607","Orphanet_881","HP_0100608","MONDO_0005148"],"count":41},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and has 3 approved and 29 investigational indications."}
{"id":"CHEMBL71611","canonicalSmiles":"Nc1c(F)cc(S(=O)(=O)Nc2nnc(S(N)(=O)=O)s2)cc1Cl","inchiKey":"HOLJYLOVIHBQHO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL71611","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06891"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL72388","canonicalSmiles":"Cc1cn([C@@H]2O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]2O)c(=O)nc1N","inchiKey":"NJQONZSFUKNYOY-JXOAFFINSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL72388","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01995"],"chEBI":["74725"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL81","canonicalSmiles":"O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12","inchiKey":"GZUITABIAKMVPG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"RALOXIFENE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Eviden","Evista","J22.982B","Keoxifene","LY-139481","NSC-747974","Raloxifene","Raloxiphene","Raxeto"],"crossReferences":{"DailyMed":["raloxifene%20hydrochloride"],"PubChem":["104171230","11111733","11111734","144209801","174007256","26755239","50105675","90341181"],"Wikipedia":["Raloxifene"],"drugbank":["DB00481"],"chEBI":["8772"]},"childChemblIds":["CHEMBL1116"],"linkedTargets":{"rows":["ENSG00000140009"],"count":1},"linkedDiseases":{"rows":["EFO_0000694","MONDO_0005090","HP_0000938","MONDO_0002050","EFO_0003854","MONDO_0011962","MONDO_0004975","MONDO_0007254","EFO_0000673","EFO_0003882","EFO_0005411","EFO_0000660","EFO_0003922"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and is indicated for breast cancer and osteoporosis and has 12 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL827","canonicalSmiles":"COC(=O)[C@H](c1ccccc1)[C@H]1CCCCN1","inchiKey":"DUGOZIWVEXMGBE-CHWSQXEVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXMETHYLPHENIDATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dexmethylphenidate","Methylphenidate d-threo-form"],"crossReferences":{"DailyMed":["dexmethylphenidate%20hydrochloride"],"Wikipedia":["Dexmethylphenidate"],"drugbank":["DB06701"],"chEBI":["51860"]},"childChemblIds":["CHEMBL904"],"linkedTargets":{"rows":["ENSG00000103546","ENSG00000142319"],"count":2},"linkedDiseases":{"rows":["EFO_0003888"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for attention deficit hyperactivity disorder."}
{"id":"CHEMBL877","canonicalSmiles":"NC[C@H]1CC[C@H](C(=O)O)CC1","inchiKey":"GYDJEQRTZSCIOI-LJGSYFOKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRANEXAMIC ACID","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cyklo-f heavy period relief","Cyklokapron","Exacyl","Lysteda","Menstralite","Tranexamic acid"],"synonyms":["Amcha","CL 65336","CL-65336","Cyclo-f","Cyclocapron","Cyclokapron","Espercil","Femstrual","Haematrix","LB-1148","LB1148","NSC-291305","RP-18429","Rikavarin","TRANS AMCHA","TRANS-AMCHA","Tranexamic acid","Trans AMCHA","Transamin"],"crossReferences":{"DailyMed":["tranexamic%20acid"],"Wikipedia":["Tranexamic_acid"],"drugbank":["DB00302"],"chEBI":["48669"]},"linkedTargets":{"rows":["ENSG00000122194"],"count":1},"linkedDiseases":{"rows":["EFO_0007442","HP_0002105","HP_0002239","EFO_1001178","EFO_0009373","MONDO_0004567","EFO_0005669","EFO_0003964","EFO_0003931","EFO_0004253","Orphanet_1531","EFO_0004616","Orphanet_98878","HP_0008419","Orphanet_2495","EFO_0009512","EFO_0001642","MONDO_0008170","EFO_0004286","EFO_0009516","MONDO_0044881","HP_0001873","EFO_0000546","MP_0001914","HP_0031364","HP_0100806","MONDO_0100096","EFO_1000391","HP_0003040","EFO_0000731","EFO_0004284","EFO_0003907","EFO_1000999","HP_0031273","EFO_1001792","EFO_0005251","EFO_0004214","MONDO_0000726","EFO_0006834","HP_0000132","EFO_0009579","EFO_0000272","EFO_0008553","Orphanet_91378","MONDO_0001187","EFO_0005531","EFO_1001801","EFO_0000326","EFO_0004272","EFO_0007490","EFO_0003963","EFO_0001645","EFO_1000350","EFO_0004198","HP_0003418","EFO_0003843","EFO_0000311","EFO_0000713","EFO_0010680","EFO_0007440","MONDO_0021148","MONDO_0021392","Orphanet_774","EFO_0004273","EFO_0005611","MONDO_0043510","EFO_0009314","EFO_0003833","MONDO_0005178","EFO_0000691","EFO_0003895","EFO_0004710"],"count":72},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and has 3 approved and 53 investigational indications."}
